Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

Clinical trial NCT02530489 · COMPLETED

Trial details

NCT number: NCT02530489
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Adenocarcinoma Invasive Breast Carcinoma Triple-Negative Breast Carcinoma

Start date: 2016-02-04
Primary completion: 2025-05-23
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.